An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease
Shi Du Yan, David M. Stern(Augusta University), Eric Stern(Columbia University), Kate S. Collison(King Faisal Specialist Hospital & Research Centre), Claudio Soto, Alex E. Roher(Barrow Neurological Institute), Xi Chen(Tsinghua University), Futwan Al‐Mohanna(King Faisal Specialist Hospital & Research Centre), Huaijie Zhu(Columbia University), Aiping Zhu(Columbia University), Masaya Tohyama(Kanazawa University), Jin Fu(Columbia University), Satoshi Ogawa(The University of Osaka), Takaomi C. Saido(RIKEN Center for Brain Science)
Cited by 376
Related Papers
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
|Nature|2000|941
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799